| Pathogenesis of human systemic lupus erythematosus: recent advances JC Crispín, SNC Liossis, K Kis-Toth, LA Lieberman, VC Kyttaris, YT Juang, ... Trends in molecular medicine 16 (2), 47-57, 2010 | 495 | 2010 |
| Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study D Daoussis, SNC Liossis, AC Tsamandas, C Kalogeropoulou, A Kazantzi, ... Rheumatology 49 (2), 271-280, 2010 | 466 | 2010 |
| Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta … SN Liossis, XZ Ding, GJ Dennis, GC Tsokos The Journal of clinical investigation 101 (7), 1448-1457, 1998 | 404 | 1998 |
| B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. SN Liossis, B Kovacs, G Dennis, GM Kammer, GC Tsokos The Journal of clinical investigation 98 (11), 2549-2557, 1996 | 302 | 1996 |
| Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitis D Daoussis, SNC Liossis, EE Solomou, A Tsanaktsi, K Bounia, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2010 | 286 | 2010 |
| Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis D Daoussis, SC Liossis, AC Tsamandas, C Kalogeropoulou, ... Clinical and Experimental Rheumatology-Incl Supplements 30 (2), S17, 2012 | 228 | 2012 |
| Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease SNC Liossis, A Bounas, AP Andonopoulos Rheumatology 45 (8), 1005-1008, 2006 | 227 | 2006 |
| Fcϵ receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus EJ Enyedy, MP Nambiar, SNC Liossis, G Dennis, GM Kammer, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 221 | 2001 |
| A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease D Daoussis, K Melissaropoulos, G Sakellaropoulos, I Antonopoulos, ... Seminars in arthritis and rheumatism 46 (5), 625-631, 2017 | 215 | 2017 |
| The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal CG Katsiari, SNC Liossis, PP Sfikakis Seminars in arthritis and rheumatism 39 (6), 491-503, 2010 | 209 | 2010 |
| Overexpression of the heat shock protein 70 enhances the TCR/CD3-and Fas/Apo-1/CD95-mediated apoptotic cell death in Jurkat T cells. SN Liossis, XZ Ding, JG Kiang, GC Tsokos Journal of immunology (Baltimore, Md.: 1950) 158 (12), 5668-5675, 1997 | 184 | 1997 |
| Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells SNC Liossis, PP Sfikakis Clinical immunology 127 (3), 280-285, 2008 | 175 | 2008 |
| B-cell kinase lyn deficiency in patients with systemic lupus erythematosus SNC Liossis, EE Solomou, MA Dimopoulos, P Panayiotidis, ... Journal of Investigative Medicine 49 (2), 157-165, 2001 | 174 | 2001 |
| Immune cell signaling defects in lupus: activation, anergy and death GC Tsokos, SNC Liossis Immunology today 20 (3), 119-124, 1999 | 162 | 1999 |
| Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials LA Saketkoo, S Mittoo, D Huscher, D Khanna, PF Dellaripa, O Distler, ... Thorax 69 (834), 436-444, 2013 | 134 | 2013 |
| The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis GDKSNC Liossis Expert Opinion on Investigational Drugs 17 (3), 349-359, 2008 | 133 | 2008 |
| Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial GD Kalliolias, PE Georgiou, IA Antonopoulos, AP Andonopoulos, ... Annals of the Rheumatic Diseases 66 (6), 842-843, 2007 | 118 | 2007 |
| Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus CG Katsiari, SNC Liossis, VL Souliotis, AM Dimopoulos, MN Manoussakis, ... Clinical immunology 103 (1), 54-62, 2002 | 112 | 2002 |
| Biologics in SAPHO syndrome: a systematic review D Daoussis, G Konstantopoulou, P Kraniotis, L Sakkas, SN Liossis Seminars in arthritis and rheumatism 48 (4), 618-625, 2019 | 111 | 2019 |
| Targeting CD40L: a promising therapeutic approach D Daoussis, AP Andonopoulos, SNC Liossis Clinical and Vaccine Immunology 11 (4), 635-641, 2004 | 109 | 2004 |
Dimitrios DaoussisUniversity of Patras Medical School, Deparment of RheumatologyVerified email at upatras.gr
